Literature DB >> 9313021

Selecting and appraising studies for a systematic review.

M O Meade1, W S Richardson.   

Abstract

After thoroughly searching the potentially relevant literature for a systematic review, reviewers face the sequential tasks of selecting studies for inclusion and appraising these studies. Methodical, impartial, and reliable strategies are necessary for these two tasks because systematic reviews are retrospective exercises and are therefore prone to both bias and random error. To plan for study selection, reviewers begin with a focused clinical question and choose selection criteria that reflect this question. A detailed selection protocol that specifies the study designs and publication status of articles to be included is often helpful. Selection criteria are itemized on customized forms and are used to examine each potentially relevant primary study, usually by two different reviewers. In planning the critical appraisal of included studies, reviewers decide which clinical and methodologic study features require documentation. After choosing methods for evaluating study quality, reviewers construct customized appraisal forms and an explicit protocol for the actual evaluation. Some of the techniques commonly used to minimize the potential for error in study appraisal include duplicate, independent examination; blinding to study results and other identifying features of each article; and correspondence with study authors to clarify issues. Ultimately, primary studies should be selected, appraised, and reported in sufficient detail to allow readers to judge the applicability of the review to clinical practice and to clarify the strength of the inferences that can be drawn from the review.

Mesh:

Year:  1997        PMID: 9313021     DOI: 10.7326/0003-4819-127-7-199710010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  24 in total

Review 1.  Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Authors:  E Oger; P Y Scarabin
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 2.  Bevacizumab increases risk for severe proteinuria in cancer patients.

Authors:  Shenhong Wu; Christi Kim; Lea Baer; Xiaolei Zhu
Journal:  J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 10.121

Review 3.  Radon therapy for the treatment of rheumatic diseases--review and meta-analysis of controlled clinical trials.

Authors:  Albrecht Falkenbach; J Kovacs; A Franke; K Jörgens; K Ammer
Journal:  Rheumatol Int       Date:  2003-12-12       Impact factor: 2.631

Review 4.  Clinical practice guidelines: what they are, why we need them and how they should be developed through rigorous evaluation.

Authors:  Cristina Cecamore; Alessandra Savino; Roberta Salvatore; Alessandro Cafarotti; Piernicola Pelliccia; Angelika Mohn; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2010-12-07       Impact factor: 3.183

Review 5.  The risk for anemia with targeted therapies for solid tumors.

Authors:  Sandro Barni; Mary Cabiddu; Paolo Guarneri; Veronica Lonati; Fausto Petrelli
Journal:  Oncologist       Date:  2012-04-24

Review 6.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  J J Swigris; W G Kuschner; S S Jacobs; S R Wilson; M K Gould
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

Review 7.  How is the experience of pain measured in older, community-dwelling people with osteoarthritis? A systematic review of the literature.

Authors:  Katie de Luca; Lynne Parkinson; Henry Pollard; Julie Byles; Fiona Blyth
Journal:  Rheumatol Int       Date:  2015-04-14       Impact factor: 2.631

Review 8.  The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis.

Authors:  Alan E Jones; Michael D Brown; Stephen Trzeciak; Nathan I Shapiro; John S Garrett; Alan C Heffner; Jeffrey A Kline
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

Review 9.  Outcome measures utilized in clinical trials of interventions for post-cardiac arrest syndrome: a systematic review.

Authors:  Stephen Trzeciak; Alan E Jones; J Hope Kilgannon; Brian M Fuller; Brian W Roberts; Joseph E Parrillo; John T Farrar
Journal:  Resuscitation       Date:  2009-04-21       Impact factor: 5.262

Review 10.  Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.

Authors:  C Angebault; A Andremont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-27       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.